Tratamiento de los ictus en la infancia

Translated title of the contribution: Stroke therapy in childrens

J. Biller, Linda Williams, Deborah Sokol, M. Cohen, B. P. Garg

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective. To evaluate the treatment modalities used in children (ages 1-18 years) with cerebral infarction. Background. Cerebrovascular disease in children is more common than once suspected but its treatment has not been rigorously studied. Material and methods. We reviewed all cases of cerebral infarction at the James Whitcomb Riley Hospital for Children at the Indiana University Medical Center from 0.1.01.80 to 31.12.95. Results. Ninety-three children who experienced ischemic strokes were followed over the past fifteen years. Fifty-seven males and thirty-six females comprised the sample. Mean age was 6.9 years at the time of stroke. No medication or surgical intervention was the therapeutic recommendation in 44% of patients. For cardioembolic strokes, warfarin was used later in the course for a few patients who went on to have atrial fibrillation or valve replacement. Aspirin was used in all patients with carotid artery dissections. Aspirin was used in most children with Moya-Moya, with calcium channel blockers and surgical intervention used in later cases. Exchange transfusion followed by monthly transfusion and chelation therapy has been the treatment of choice for children with cerebral infarction complicating sickle cell disease. Conclusion. In most instances, treatment was widely disparate, probably reflecting the lack of firm therapeutic guidelines for this age group, with a better understanding of the etiology and pathophysiology of strokes in children, multicenter, international, randomized therapeutic trials based strictly on an etiological basis should be organized in the future.

Original languageSpanish
Pages (from-to)923-926
Number of pages4
JournalRevista de Neurologia
Volume25
Issue number142
StatePublished - Jun 1997

Fingerprint

Stroke
Cerebral Infarction
Therapeutics
Aspirin
Chelation Therapy
Cerebrovascular Disorders
Calcium Channel Blockers
Sickle Cell Anemia
Warfarin
Carotid Arteries
Atrial Fibrillation
Dissection
Age Groups
Guidelines

Keywords

  • Cerebral infarction
  • Children
  • Therapy

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Biller, J., Williams, L., Sokol, D., Cohen, M., & Garg, B. P. (1997). Tratamiento de los ictus en la infancia. Revista de Neurologia, 25(142), 923-926.

Tratamiento de los ictus en la infancia. / Biller, J.; Williams, Linda; Sokol, Deborah; Cohen, M.; Garg, B. P.

In: Revista de Neurologia, Vol. 25, No. 142, 06.1997, p. 923-926.

Research output: Contribution to journalArticle

Biller, J, Williams, L, Sokol, D, Cohen, M & Garg, BP 1997, 'Tratamiento de los ictus en la infancia', Revista de Neurologia, vol. 25, no. 142, pp. 923-926.
Biller J, Williams L, Sokol D, Cohen M, Garg BP. Tratamiento de los ictus en la infancia. Revista de Neurologia. 1997 Jun;25(142):923-926.
Biller, J. ; Williams, Linda ; Sokol, Deborah ; Cohen, M. ; Garg, B. P. / Tratamiento de los ictus en la infancia. In: Revista de Neurologia. 1997 ; Vol. 25, No. 142. pp. 923-926.
@article{c792e00f2908405e86a976295ac25ae3,
title = "Tratamiento de los ictus en la infancia",
abstract = "Objective. To evaluate the treatment modalities used in children (ages 1-18 years) with cerebral infarction. Background. Cerebrovascular disease in children is more common than once suspected but its treatment has not been rigorously studied. Material and methods. We reviewed all cases of cerebral infarction at the James Whitcomb Riley Hospital for Children at the Indiana University Medical Center from 0.1.01.80 to 31.12.95. Results. Ninety-three children who experienced ischemic strokes were followed over the past fifteen years. Fifty-seven males and thirty-six females comprised the sample. Mean age was 6.9 years at the time of stroke. No medication or surgical intervention was the therapeutic recommendation in 44{\%} of patients. For cardioembolic strokes, warfarin was used later in the course for a few patients who went on to have atrial fibrillation or valve replacement. Aspirin was used in all patients with carotid artery dissections. Aspirin was used in most children with Moya-Moya, with calcium channel blockers and surgical intervention used in later cases. Exchange transfusion followed by monthly transfusion and chelation therapy has been the treatment of choice for children with cerebral infarction complicating sickle cell disease. Conclusion. In most instances, treatment was widely disparate, probably reflecting the lack of firm therapeutic guidelines for this age group, with a better understanding of the etiology and pathophysiology of strokes in children, multicenter, international, randomized therapeutic trials based strictly on an etiological basis should be organized in the future.",
keywords = "Cerebral infarction, Children, Therapy",
author = "J. Biller and Linda Williams and Deborah Sokol and M. Cohen and Garg, {B. P.}",
year = "1997",
month = "6",
language = "Spanish",
volume = "25",
pages = "923--926",
journal = "Revista de Neurologia",
issn = "0210-0010",
publisher = "Revista de Neurologia",
number = "142",

}

TY - JOUR

T1 - Tratamiento de los ictus en la infancia

AU - Biller, J.

AU - Williams, Linda

AU - Sokol, Deborah

AU - Cohen, M.

AU - Garg, B. P.

PY - 1997/6

Y1 - 1997/6

N2 - Objective. To evaluate the treatment modalities used in children (ages 1-18 years) with cerebral infarction. Background. Cerebrovascular disease in children is more common than once suspected but its treatment has not been rigorously studied. Material and methods. We reviewed all cases of cerebral infarction at the James Whitcomb Riley Hospital for Children at the Indiana University Medical Center from 0.1.01.80 to 31.12.95. Results. Ninety-three children who experienced ischemic strokes were followed over the past fifteen years. Fifty-seven males and thirty-six females comprised the sample. Mean age was 6.9 years at the time of stroke. No medication or surgical intervention was the therapeutic recommendation in 44% of patients. For cardioembolic strokes, warfarin was used later in the course for a few patients who went on to have atrial fibrillation or valve replacement. Aspirin was used in all patients with carotid artery dissections. Aspirin was used in most children with Moya-Moya, with calcium channel blockers and surgical intervention used in later cases. Exchange transfusion followed by monthly transfusion and chelation therapy has been the treatment of choice for children with cerebral infarction complicating sickle cell disease. Conclusion. In most instances, treatment was widely disparate, probably reflecting the lack of firm therapeutic guidelines for this age group, with a better understanding of the etiology and pathophysiology of strokes in children, multicenter, international, randomized therapeutic trials based strictly on an etiological basis should be organized in the future.

AB - Objective. To evaluate the treatment modalities used in children (ages 1-18 years) with cerebral infarction. Background. Cerebrovascular disease in children is more common than once suspected but its treatment has not been rigorously studied. Material and methods. We reviewed all cases of cerebral infarction at the James Whitcomb Riley Hospital for Children at the Indiana University Medical Center from 0.1.01.80 to 31.12.95. Results. Ninety-three children who experienced ischemic strokes were followed over the past fifteen years. Fifty-seven males and thirty-six females comprised the sample. Mean age was 6.9 years at the time of stroke. No medication or surgical intervention was the therapeutic recommendation in 44% of patients. For cardioembolic strokes, warfarin was used later in the course for a few patients who went on to have atrial fibrillation or valve replacement. Aspirin was used in all patients with carotid artery dissections. Aspirin was used in most children with Moya-Moya, with calcium channel blockers and surgical intervention used in later cases. Exchange transfusion followed by monthly transfusion and chelation therapy has been the treatment of choice for children with cerebral infarction complicating sickle cell disease. Conclusion. In most instances, treatment was widely disparate, probably reflecting the lack of firm therapeutic guidelines for this age group, with a better understanding of the etiology and pathophysiology of strokes in children, multicenter, international, randomized therapeutic trials based strictly on an etiological basis should be organized in the future.

KW - Cerebral infarction

KW - Children

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0030944081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030944081&partnerID=8YFLogxK

M3 - Article

C2 - 9244630

AN - SCOPUS:0030944081

VL - 25

SP - 923

EP - 926

JO - Revista de Neurologia

JF - Revista de Neurologia

SN - 0210-0010

IS - 142

ER -